Perspective Therapeutics (CATX) Current Leases (2019 - 2026)
Perspective Therapeutics (CATX) posted Current Leases of $1.1 million for Q1 2026, up 71.59% sequentially from $623000.0 in Q4 2025, and up 9.08% YoY from $980000.0 in Q1 2025.
Perspective Therapeutics (CATX) Current Leases (2019 - 2026) Analysis & Trends
Perspective Therapeutics has reported Current Leases for 8 years, with the latest figure at $1.1 million in Q1 2026.
- Quarterly Current Leases rose 9.08% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 9.08% YoY) and the FY2025 annual result came in at $623000.0, down 34.9% from the prior year.
- Current Leases rose to $1.1 million in Q1 2026 per CATX's latest filing, from $623000.0 in the prior quarter.
- Over five years, Current Leases peaked at $1.1 million in Q1 2026 and troughed at $46000.0 in Q4 2023.
- A 5-year average of $538500.0 and a median of $458000.0 in 2023 frame the typical range for Current Leases.
- The widest YoY moves for Current Leases: up 1980.43% in 2024, down 54.29% in 2024.
- Over 5 years, Current Leases stood at $272000.0 in 2022, then sank by 83.09% to $46000.0 in 2023, then soared by 1980.43% to $957000.0 in 2024, then tumbled by 34.9% to $623000.0 in 2025, then surged by 71.59% to $1.1 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $1.1 million, $623000.0, and $704000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 24.10 Mn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 20.70 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | - |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 35.60 Mn |
| 10 | Perspective Therapeutics | 384.27 Mn | 384.27 Mn | - | 1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.10 Mn |
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 623,000.00 |
| Sep 30, 2025 | 704,000.00 |
| Jun 30, 2025 | 847,000.00 |
| Mar 31, 2025 | 980,000.00 |
| Dec 31, 2024 | 957,000.00 |
| Sep 30, 2024 | 903,000.00 |
| Jun 30, 2024 | 720,000.00 |
| Mar 31, 2024 | 128,000.00 |
| Dec 31, 2023 | 46,000.00 |
| Sep 30, 2023 | 293,000.00 |
| Jun 30, 2023 | 262,000.00 |
| Mar 31, 2023 | 280,000.00 |
| Sep 30, 2022 | 272,000.00 |
| Jun 30, 2022 | 268,000.00 |
| Mar 31, 2022 | 264,000.00 |
| Dec 31, 2021 | 260,000.00 |
| Sep 30, 2021 | 256,000.00 |
| Jun 30, 2021 | 252,000.00 |